Below are 10 news articles from the past 7 days regarding COVID-19 to help guide you in making your decision. Using your best judgement, take into consideration only the articles that are most relevant for forecasting COVID-19 hospitalizations in Ontario, Canada. Articles that are from know reputable sources have been flagged with "Trusted: True".

Article 1 of 10
Title: COVID-19 vaccine: How was it developed so fast?
Publisher: Medical News Today
Trusted: False
Posted: 1 day ago
The COVID-19 pandemic has spurred global cooperation in vaccine research and development, with healthcare workers administering billions of vaccine doses. The rapid development of the vaccine has led to concerns about its safety and effectiveness, and vaccine hesitancy remains an issue. Transparency and communication about the vaccine process are key to building public trust. Researchers were not starting from scratch with SARS-CoV-2, as it is a member of the coronavirus family that has been studied for over 50 years. Worldwide collaboration and data sharing accelerated the identification of the viral sequence, allowing for faster research and clinical trials. Funding from governments and the private sector was also crucial in vaccine development. The Pfizer and Moderna vaccines are the first mRNA vaccines used outside of clinical trials. mRNA vaccines deliver the genetic material of the coronavirus spike protein, training the immune system to recognize and attack the virus. Misinformation and misconceptions surround mRNA vaccines, including concerns about infection and the vaccine's effectiveness against mutations. However, experts clarify that the vaccine does not infect people, and the low mutation rate of SARS-CoV-2 means that the spike protein is unlikely to mutate enough to render vaccines ineffective. Clinical trials for the COVID-19 vaccines followed rigorous guidelines, with multiple phases focusing on safety, efficacy, and immune response. The rapid completion of trials was due to high volunteer participation and an increased number of testing sites. Even after emergency use authorization, scientists continue to collect safety data and monitor for any adverse events. The CDC has found that COVID-19 mRNA vaccines are much more effective in preventing hospitalization than a previous infection, emphasizing that vaccine-acquired immunity is preferable to natural immunity.

Article 2 of 10
Title: Explained: Why RNA vaccines for Covid-19 raced to the front of the pack
Publisher: MIT News
Trusted: False
Posted: 1 day ago
The article discusses the development and testing of mRNA vaccines for COVID-19, highlighting their potential advantages and drawbacks. Here is a summary: The typical vaccine development timeline is 12-18 months, but COVID-19 mRNA vaccines were developed and submitted for FDA emergency use authorization in just over 10 months. mRNA vaccines use synthetic mRNA to instruct cells to produce a viral protein, stimulating an immune response without causing infection. A key advantage of mRNA vaccines is their ease of synthesis once the sequence of the target viral protein is known. Most COVID-19 vaccines target the coronavirus spike protein. mRNA vaccines are delivered using lipid nanoparticles, protecting the RNA and facilitating its entry into cells. The first lipid nanoparticle carrier for RNA was approved by the FDA in 2018 and was developed to deliver siRNA, which silences target genes. One drawback of mRNA vaccines is their instability at high temperatures, requiring cold storage. However, adding stabilizers and removing water through lyophilization can improve stability. The high effectiveness of the Pfizer and Moderna COVID-19 mRNA vaccines in phase 3 trials (approximately 95%) offers hope for ending the pandemic and for future applications of RNA vaccines against other diseases. To forecast COVID-19 hospitalizations, it is important to consider the effectiveness of these vaccines. The high effectiveness rates in clinical trials suggest that widespread vaccination could significantly reduce the number of hospitalizations by preventing severe cases of COVID-19. However, the impact on hospitalizations will also depend on vaccine distribution, uptake, and the emergence of new variants.

Article 3 of 10
Title: Here's the COVID-19 vaccine rollout plan, province by province
Publisher: CBC.ca
Trusted: False
Posted: 2 days ago
Health Canada has approved the Pfizer-BioNTech COVID-19 vaccine, with priority populations expected to receive it as early as next week and a tentative rollout for the general population in spring. Provinces are preparing their distribution plans, with varying timelines and priority groups. Here are the key points from the article: Alberta will receive about 3,900 doses next week, targeting ICU doctors, nurses, respiratory therapists, and long-term care workers first. Ontario will start administering vaccines on Tuesday in Toronto and Ottawa, focusing on healthcare workers in long-term care homes. Manitoba expects to vaccinate over 100,000 people by March 31, 2021, with the first doses going to critical care health workers. Saskatchewan will begin vaccinating healthcare workers at Regina General Hospital next week, with Phase 1 focusing on high-risk groups. British Columbia aims to immunize 400,000 people by March, prioritizing long-term care residents, staff, and healthcare workers. Quebec will likely have a limited number of doses next week, starting with patients in residential and long-term care centers. New Brunswick expects the first doses around December 14, with long-term care residents, staff, health-care workers, and seniors as priorities. Newfoundland and Labrador will receive vaccine doses next week, with distribution plans focusing on high-risk groups. Prince Edward Island could receive the first doses next week, vaccinating 1,000 people, starting with long-term care residents and staff. Nova Scotia will receive 1,950 doses this month, targeting frontline healthcare workers first. The territories won't receive the Pfizer-BioNTech vaccine due to freezer requirements but are expected to receive the Moderna vaccine, with Yukon aiming to vaccinate all adults who want it within the first quarter of 2021.

Article 4 of 10
Title: New interdisciplinary course introduces Laurier students to complex dynamics of the COVID-19 pandemic
Publisher: Wilfrid Laurier University
Trusted: True
Posted: 2 days ago
The article discusses a new interdisciplinary course at Wilfrid Laurier University that introduces students to the complex dynamics of the COVID-19 pandemic. The course, "COVID-19: From Cell to Society," offered through the Department of Health Sciences, focuses on helping students understand the different ways people and populations experience and respond to the pandemic. Here are some important facts from the article that could be relevant for forecasting COVID-19 hospitalizations: The course highlights the complexity of the pandemic and its impact on various aspects of society, including virology, immunology, epidemiology, public health, history, geography, communication studies, and psychology. Students will learn about the virus that causes COVID-19, SARS-CoV-2, how it infects people, and how it transmits between them. The course will explain how the human body responds to the virus and introduce the concept of herd immunity, which is important for understanding infection rates and the potential relief on the healthcare system. The psychological impact of the pandemic will be addressed, including common struggles and coping mechanisms, which could indirectly influence hospitalization rates as mental health issues may lead to physical health deterioration. The course will also discuss the role of storytelling and misinformation in shaping public perception and behavior, which could impact hospitalization rates as misinformation may lead to incorrect beliefs about the severity of the disease or the effectiveness of treatments. Finally, the course will touch on the disproportionate impact of COVID-19 on certain communities, which could help forecast hospitalizations by identifying at-risk groups and the potential strain on healthcare resources. Overall, the course aims to provide a comprehensive understanding of the COVID-19 pandemic and its impact on society, which could be valuable for forecasting COVID-19 hospitalizations by identifying key factors that influence infection rates, disease severity, and healthcare-seeking behaviors.

Article 5 of 10
Title: Can COVID-19 be transmitted through food?
Publisher: McGill University
Trusted: True
Posted: 2 days ago
The article explores the possibility of COVID-19 being transmitted through food, a concern that has been raised due to the nature of respiratory viruses like COVID-19 and influenza. While respiratory droplets are the primary means of transmission, there is a theoretical possibility that these viruses could be deposited on food items and transmitted through consumption. However, the authors emphasize that to date, there have been no recorded cases of COVID-19 acquired from food, nor are there any outbreaks suggesting a food source. They conclude that while foodborne transmission is theoretically possible, it is unlikely. Nonetheless, there are unanswered questions about SARS-CoV-2's viability on food and its behavior in the gastrointestinal tract, which could impact our understanding of its transmission. Current recommendations for food safety, such as handwashing and proper handling/cooking of food, are considered adequate to mitigate the risk of SARS-CoV-2 transmission through food. This knowledge can help in forecasting hospitalizations by focusing on respiratory transmission and other known routes of infection, without needing to consider foodborne transmission as a significant factor.

Article 6 of 10
Title: Comirnaty (tozinameran)
Publisher: COVID-19 vaccines and treatments portal
Trusted: False
Posted: 3 days ago
Here is a summary of the document, which includes important information for forecasting COVID-19 hospitalizations: The document provides an overview of various resources and information related to the Pfizer-BioNTech COVID-19 Vaccine for consumers, health care professionals, and researchers in Canada. It includes details about the product monograph, regulatory decisions, adverse events, storage and administration, and more. For consumers: The Product Monograph provides scientific information about the vaccine, including its properties, indications, dosage, warnings, and side effects. The Regulatory Decision Summary explains Health Canada's decision to authorize the vaccine, including the reasons and any terms and conditions. Public advisories and risk communications are published by Health Canada to share updates and important information about the vaccine. For health care professionals: The interim product and package labels are provided for the initial supply of the vaccine with English-only labeling. Storage, handling, and administration guides are available, providing instructions on the proper use of the vaccine. Information about low dead-volume syringes and needles is included for healthcare professionals. For researchers: The Summary Basis of Decision explains why Health Canada approved the vaccine for use in Canada, including safety, effectiveness, and quality considerations. The Post-Authorization Activity Table summarizes any activities and updates after the vaccine's approval. Clinical information from the regulatory review process is made publicly available for non-commercial use. The document also includes a Risk Management Plan from the company, which outlines known and potential safety issues, monitoring plans, and risk minimization measures. While the document does not provide direct forecasts or predictions for COVID-19 hospitalizations, the information within can help inform projections. The availability of vaccine information, including its authorization, adverse events, and clinical data, can be used by public health officials and researchers to make informed decisions and predictions about COVID-19 hospitalizations. Additionally, the vaccine's effectiveness data and real-world usage can provide insights into its impact on reducing severe disease and hospitalizations.

Article 7 of 10
Title: How the Coronavirus Outbreak Has – and Hasn’t – Changed the Way Americans Work
Publisher: Pew Research Center
Trusted: False
Posted: 3 days ago
This Pew Research Center survey examines the impact of the COVID-19 pandemic on the work experiences of employed adults in the United States. The survey finds that many workers have transitioned to remote work, with 71% of those who can mainly work from home now doing so all or most of the time. This marks a significant shift, as most of these workers rarely or never worked from home before the pandemic. The transition to telework has been relatively easy for many, with most reporting easy access to the necessary technology and equipment, as well as adequate workspace. However, there is a clear class divide, with 62% of workers with a bachelor's degree or higher saying their work can be done from home, compared to only 23% of those without a college degree. The survey also finds that a majority of workers who are not currently teleworking have in-person interactions at their workplace, with 52% interacting with others a lot. Many of these workers are concerned about exposure to COVID-19 and are satisfied with the protective measures in place. While the pandemic has changed how many workers do their jobs, most report no significant change in job satisfaction, productivity, or security. However, those who have transitioned to telework report both upsides and downsides, with increased flexibility but also feeling less connected to coworkers. The survey also examines the demographics of those who can work from home, with higher-income and educated workers more likely to have this option. Additionally, the ability to work from home varies by industry, with those in information technology, banking, education, and professional services more likely to be able to telework. Overall, the survey provides insights into how the COVID-19 pandemic has shaped the work landscape in the United States and the potential long-term impacts on remote work.

Article 8 of 10
Title: BC COVID-19 SPEAK Survey
Publisher: Island Health
Trusted: False
Posted: 3 days ago
The BC COVID-19 SPEAK survey, with nearly 400,000 participants from British Columbia, reveals a mixed bag of impacts due to the pandemic and the subsequent response measures. The survey covers various factors, including personal experiences, resilience, and impacts on healthcare, social connections, and economic conditions. Mental health has been a significant concern during the pandemic, and the survey shows that nearly half of the respondents from Island Health reported a decline in their mental health, especially those aged 18-29 and individuals with children. A sense of community belonging is linked to better mental health, and overall, 67% of Island Health respondents felt a strong sense of community. Younger respondents, however, reported a weaker sense of community belonging. On a positive note, over 80% of Island Health respondents approved of the initial public health response, the highest among all health authorities. The detailed data from this survey will help analysts and epidemiologists understand the impacts at a community level and work with partners to address any negative consequences and build on the positive ones. This survey provides valuable insights to help forecast COVID-19 hospitalizations by identifying at-risk groups and communities. The mental health decline, especially among young people and those with children, could potentially lead to increased hospitalizations in the future. Additionally, the approval of the public health response suggests that clear and effective communication can play a crucial role in maintaining public trust and cooperation with health measures.

Article 9 of 10
Title: Building resilient Arctic science amid the COVID-19 pandemic
Publisher: Nature.com
Trusted: False
Posted: 4 days ago
The article discusses the impact of the COVID-19 pandemic on Arctic science and the need to prioritize local communities and knowledge in future research efforts. Here is a summary, including some important facts to help forecast COVID-19 hospitalizations: Doing no harm: Arctic scientists must avoid travel to Arctic communities to prevent the spread of COVID-19 until risks are eliminated. This will result in a shift in how scientific discovery in the Arctic is conducted in the short and long term. Embracing the 'local turn' and knowledge co-production: The pandemic has emphasized the need for a permanent presence of science in the Arctic. Investing in Arctic infrastructure, such as field stations and community observation systems, and re-focusing on localized operations are necessary steps. This shift towards localization must also involve decolonizing Arctic science and integrating Indigenous, traditional, and local knowledge systems. Meaningful collaboration and equitable partnerships with Indigenous and local communities are crucial to improve science and empower communities. Focusing on the next generation: The interruption in training during the pandemic underscores the importance of providing place-based learning and training opportunities for the next generation of scientists, both from southern institutions and Arctic residents. Developing educational programs and research opportunities that focus on Indigenous and local communities' contexts and address social, historical, political, and economic circumstances in the Arctic is essential. The Arctic as an essential arena for global research: The COVID-19 pandemic's economic and social impacts will likely have long-lasting effects. However, the rapidly changing environmental impacts emphasize the vital need for in situ scientific studies. Personal field experiences, community-driven knowledge co-production, and hands-on learning and teaching are crucial for transferring knowledge to future generations of Arctic experts. The research community must continue to emphasize the importance of understanding the Arctic as a significant global challenge. Overall, the article calls for a more localized, collaborative, and equitable approach to Arctic science in the post-COVID-19 world, prioritizing the involvement and empowerment of Indigenous and local communities. Building resilient knowledge-building systems, embracing international cooperation, and pursuing well-coordinated global initiatives will contribute to a better understanding of the Arctic and its importance to humankind.

Article 10 of 10
Title: Sidney’s Welcome Back to Business COVID-19 recovery campaign
Publisher: Government of B.C.
Trusted: True
Posted: 5 days ago
The "Welcome Back to Business" campaign in Sidney, a town in British Columbia, Canada, aimed to support local businesses affected by the COVID-19 pandemic and the loss of international tourism. The campaign had multiple components, including marketing, social media engagement, and COVID-19 safety education. It highlighted Sidney as a safe destination and targeted residents and nearby communities. The campaign video, showcasing local businesses and their owners, received over 50,000 views. A "Shop Local Sweepstakes" contest encouraged locals to shop in Sidney, offering them a chance to win shopping sprees and nominate small businesses for cash prizes. This campaign reached over 17,000 people. Additionally, a "Staycation in Sidney" initiative promoted local accommodations after the province entered Phase 3 of the restart plan. The campaign utilized a digital billboard along a highway, expecting to deliver approximately 3.2 million impressions. The Sidney BIA also offered online resources and consulting for businesses adapting to the pandemic. The campaign fostered collaboration between the BIA and member businesses, and residents embraced shopping local. Many businesses reported increased revenue and foot traffic. Sidney's campaign emphasized the human element of shopping local and prioritized safety, contributing to its success in supporting the local economy during the pandemic.